DENTSPLY SIRONA (NASDAQ:XRAY) Given In-Line Rating at Evercore ISI

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “in-line” rating restated by analysts at Evercore ISI in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $20.00 price target on the medical instruments supplier’s stock. Evercore ISI’s price target would indicate a potential upside of 6.04% from the stock’s previous close.

Several other brokerages also recently issued reports on XRAY. Mizuho started coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. UBS Group cut their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Barrington Research reduced their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Finally, Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $27.27.

DENTSPLY SIRONA Stock Up 1.3 %

XRAY opened at $18.86 on Tuesday. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business has a 50 day moving average price of $19.54 and a 200 day moving average price of $23.26. The firm has a market cap of $3.75 billion, a P/E ratio of -9.11, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the previous year, the company earned $0.49 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was up .4% on a year-over-year basis. Research analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Nordea Investment Management AB lifted its stake in DENTSPLY SIRONA by 245.0% during the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after purchasing an additional 178,639 shares during the period. Everence Capital Management Inc. bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $342,000. GAMMA Investing LLC raised its holdings in shares of DENTSPLY SIRONA by 155.5% in the 4th quarter. GAMMA Investing LLC now owns 6,357 shares of the medical instruments supplier’s stock worth $121,000 after buying an additional 3,869 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after buying an additional 1,244,326 shares during the period. Finally, Synovus Financial Corp acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $240,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.